EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CYTK: Cytokinetics

31 Dec 25 15:59
LAST:

63.54

CHANGE:
 2.17		OPEN:
61.12		HIGH:
64.43		ASK:
10.15		VOLUME:
1.19M
CHG(%):
3.54		PREV:
61.37		LOW:
60.93		BID:
6.61		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Dec 2561.1264.4360.9363.541.98M
30 Dec 2561.7862.4060.4261.371.66M
29 Dec 2562.4462.7261.5961.751.7M
26 Dec 2564.1464.1762.7263.111.39M
24 Dec 2563.3965.2863.2064.181.15M
23 Dec 2564.9765.2762.0063.292.91M
22 Dec 2564.0070.9863.1865.607.67M
19 Dec 2562.9363.7062.1062.721.31M
18 Dec 2562.6663.8061.2262.202.95M
17 Dec 2562.1062.2659.3759.822.02M

PROFILE

Name:Cytokinetics
About:Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK- 089, a fast skeletal muscle troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase II clinical trial; and aficamten, a novel, oral, small molecule cardiac myosin inhibitor which is in Phase III clinical trial discovered for the treatment of hypertrophic cardiomyopathy. It has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Website:https://www.cytokinetics.com
CUSIP:23282W100
CIK:0001061983
ISIN:US23282W6057
FIGI:BBG000F0R4N9
LEI:549300BE5DY1HW7IHA64

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.41 
Forward P/E:-11.80 
PEG Ratio:0.79 
Price to Sales:88.75 
Price to Book:-19.45 
Profit Margin:-17.37 
Operating Margin:-1.67 
Return on Assets:-0.25 
Return on Equity:4.35 
EPS Ratio:-5.12 
Revenue:85.74M 
Shares:119.66M 
Market Cap:7.603B 

TECHNICAL INDICATORS

MA5:62.791.2%
MA10:62.761.2%
MA20:62.941.0%
MA50:63.000.9%
MA100:55.9913.5%
MA200:45.9438.3%
STO9:22.58
STO14:33.33
RSI14:57.86
WPR14:-35.64
MTM14:2.77
ROC14:0.05 
ATR:2.84 
Week High:65.282.7%
Week Low:60.425.2%
Month High:70.9811.7%
Month Low:59.3738.3%
Year High:70.9811.7%
Year Low:29.31116.8%
Volatility:3.60 

RECENT SPLITS

Date Ratio
25 Jun 20131-6